| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 10/08/2002 | USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them |
| 10/08/2002 | US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia, |
| 10/08/2002 | US6462196 Preparation of a camptothecin derivative by intramolecular cyclization |
| 10/08/2002 | US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462086 Non-malignant disease treatment with Ras antagonists |
| 10/08/2002 | US6462075 Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/08/2002 | US6462059 Treatment of disorders associated with smooth muscle contraction; urinary incontinence, asthma, premature labor, irritable bowel syndrome, congestive heart failure, angina, and cerebral vascular disease |
| 10/08/2002 | US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 10/08/2002 | US6462053 Neuropeptide y receptor antagonists; cardiovascular and central nervous system disorders and metabolic diseases; hypertension, nephropathy, heart disease, vasospasm, arteriosclerosis |
| 10/08/2002 | US6462044 Therapy for sexual disorders |
| 10/08/2002 | US6462043 Method for producing substituted-2-nitroguanidine derivatives |
| 10/08/2002 | US6462023 Cytostatic agents |
| 10/08/2002 | US6461994 Transition metal complex compounds and polymerization catalysts based thereon, used in polymerization and copolymerization of olefins |
| 10/08/2002 | US6461388 Diaminobenzene derivative compounds and dye compositions containing same |
| 10/06/2002 | WO2003088897A2 Fab i inhibitors |
| 10/06/2002 | CA2444597A1 Fab i inhibitors |
| 10/03/2002 | WO2002077609A2 Identification of compounds for the treatment or prevention of proliferative diseases |
| 10/03/2002 | WO2002076974A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 10/03/2002 | WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 10/03/2002 | WO2002076939A2 Cysteine protease inhibitors |
| 10/03/2002 | WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity |
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 10/03/2002 | WO2002076447A1 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 10/03/2002 | WO2002076177A2 Design and synthesis of optimized ligands for ppar |
| 10/03/2002 | WO2002058631A3 Primary intermediates for oxidative coloration of hair |
| 10/03/2002 | WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors) |
| 10/03/2002 | WO2002026731A3 Quaternary amidino based inhibitors of factor xa |
| 10/03/2002 | US20020143188 Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| 10/03/2002 | US20020143187 Nitric oxide donors and pharmaceutical compositions containing them |
| 10/03/2002 | US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 10/03/2002 | US20020143054 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 10/03/2002 | US20020143036 Pentafluorobenzenesulfonamides and analogs |
| 10/03/2002 | US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 10/03/2002 | US20020143025 For preventing free radical-mediated cellular damage or disruption; as oxidation inhibitors as additives to fuels, lubricants, rubber, polymers, chemicals, solvents and foodstuffs |
| 10/03/2002 | US20020143020 Novel piperazine derivatives |
| 10/03/2002 | US20020143011 Tri-substituted phenyl derivatives and processes for their preparation |
| 10/03/2002 | US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine |
| 10/03/2002 | US20020142912 Substituted pyridyl amine complexes, and catalysts |
| 10/03/2002 | US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 10/03/2002 | CA2442364A1 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 10/03/2002 | CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/02/2002 | EP1245660A2 Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices |
| 10/02/2002 | EP1244627A1 Picolinic acid derivatives and their use as fungicides |
| 10/02/2002 | EP1244626A2 Caspase inhibitors and uses thereof |
| 10/02/2002 | EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines |
| 10/02/2002 | EP1086114B1 Morphine-6-glucuronide synthesis |
| 10/02/2002 | EP0963484B1 Sizing of paper |
| 10/02/2002 | EP0706521B1 Imides as tnf alpha inhibitors |
| 10/02/2002 | EP0689534B1 Amide derivatives as 5-ht 1a? ligands |
| 10/02/2002 | DE10115945A1 Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 10/02/2002 | DE10113587A1 Verfahren zur Herstellung von substituierten Pyrrolen A process for the preparation of substituted pyrroles |
| 10/02/2002 | CN1372550A Process for the preparation of 2-cyanopyridines |
| 10/02/2002 | CN1372549A Fungicidies |
| 10/02/2002 | CN1372548A Heterocyclic compounds and medicinal use thereof |
| 10/02/2002 | CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 10/02/2002 | CN1091623C Crystallisation process |
| 10/01/2002 | US6458998 Naphthaleneureas as antidiabetic agents |
| 10/01/2002 | US6458982 Transition metal compound, catalyst, its production and its use for the polymerization of olefins |
| 10/01/2002 | US6458957 α,α-dibromo-α-chloro-acetophenones as synthons |
| 10/01/2002 | US6458951 For treatment of male erectile dysfunction, female sexual dysfunction |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458844 Antiinflammatory agents |
| 10/01/2002 | US6458816 Anticancer agents |
| 10/01/2002 | US6458815 Cardiovascular disorders, anticholesterol agent |
| 10/01/2002 | US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer |
| 10/01/2002 | US6458806 Aryl alkenamides derivatives as MCP-1 antagonists |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458794 Potassium channel inhibitors |
| 10/01/2002 | US6458793 Heterocyclic derivatives which inhibit factor Xa |
| 10/01/2002 | US6458789 2-aminopyridine derivatives and combinatorial libraries thereof |
| 10/01/2002 | US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions |
| 10/01/2002 | US6458772 Prodrugs |
| 10/01/2002 | US6458739 Polymerization catalysts |
| 10/01/2002 | CA2209018C Sulfonamides and their use |
| 10/01/2002 | CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists |
| 09/26/2002 | WO2002074757A1 Method for producing substituted pyrroles and furans |
| 09/26/2002 | WO2002074735A2 Biurethane derivatives |
| 09/26/2002 | WO2002074733A2 Tryptase-inhibitors |
| 09/26/2002 | WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6? |
| 09/26/2002 | WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | WO2002074310A2 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 09/26/2002 | WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient |
| 09/26/2002 | WO2002036173A3 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137937 Process for preparing [S- (R*, S*) ] -beta- [ [ [1- [1-oxo-3- (4-piperidinyl) propyl] -3-piperidinyl] carbonyl]amino] -3-pyridinepropanoic acid and derivatives |
| 09/26/2002 | US20020137845 Methods of copolymerizing ethylene and isobutylene and polymers made thereby |
| 09/26/2002 | US20020137774 Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |